KRYS
Price
$153.25
Change
+$1.35 (+0.89%)
Updated
Jul 23 closing price
Capitalization
4.43B
18 days until earnings call
VKTX
Price
$33.11
Change
-$0.29 (-0.87%)
Updated
Jul 24, 01:00 PM (EDT)
Capitalization
3.75B
90 days until earnings call
Interact to see
Advertisement

KRYS vs VKTX

Header iconKRYS vs VKTX Comparison
Open Charts KRYS vs VKTXBanner chart's image
Krystal Biotech
Price$153.25
Change+$1.35 (+0.89%)
Volume$265.4K
Capitalization4.43B
Viking Therapeutics
Price$33.11
Change-$0.29 (-0.87%)
Volume$3.72K
Capitalization3.75B
KRYS vs VKTX Comparison Chart in %
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. VKTX commentary
Jul 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Buy and VKTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 24, 2025
Stock price -- (KRYS: $153.25 vs. VKTX: $33.40)
Brand notoriety: KRYS and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 78% vs. VKTX: 156%
Market capitalization -- KRYS: $4.43B vs. VKTX: $3.75B
KRYS [@Biotechnology] is valued at $4.43B. VKTX’s [@Biotechnology] market capitalization is $3.75B. The market cap for tickers in the [@Biotechnology] industry ranges from $295.06B to $0. The average market capitalization across the [@Biotechnology] industry is $2.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, VKTX is a better buy in the long-term than KRYS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 5 TA indicator(s) are bullish while VKTX’s TA Score has 6 bullish TA indicator(s).

  • KRYS’s TA Score: 5 bullish, 3 bearish.
  • VKTX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both KRYS and VKTX are a good buy in the short-term.

Price Growth

KRYS (@Biotechnology) experienced а +2.11% price change this week, while VKTX (@Biotechnology) price change was +5.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.15%. For the same industry, the average monthly price growth was +22.17%, and the average quarterly price growth was +31.45%.

Reported Earning Dates

KRYS is expected to report earnings on Nov 10, 2025.

VKTX is expected to report earnings on Oct 22, 2025.

Industries' Descriptions

@Biotechnology (+8.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KRYS($4.43B) has a higher market cap than VKTX($3.75B). KRYS YTD gains are higher at: -2.177 vs. VKTX (-16.998). KRYS has higher annual earnings (EBITDA): 140M vs. VKTX (-171.93M). VKTX has more cash in the bank: 852M vs. KRYS (617M). VKTX has less debt than KRYS: VKTX (1M) vs KRYS (9.66M). KRYS has higher revenues than VKTX: KRYS (333M) vs VKTX (0).
KRYSVKTXKRYS / VKTX
Capitalization4.43B3.75B118%
EBITDA140M-171.93M-81%
Gain YTD-2.177-16.99813%
P/E Ratio36.75N/A-
Revenue333M0-
Total Cash617M852M72%
Total Debt9.66M1M966%
FUNDAMENTALS RATINGS
KRYS vs VKTX: Fundamental Ratings
KRYS
VKTX
OUTLOOK RATING
1..100
2016
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
3672
SMR RATING
1..100
5791
PRICE GROWTH RATING
1..100
5848
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VKTX's Valuation (43) in the Biotechnology industry is in the same range as KRYS (70) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's Profit vs Risk Rating (36) in the Pharmaceuticals Major industry is somewhat better than the same rating for VKTX (72) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than VKTX’s over the last 12 months.

KRYS's SMR Rating (57) in the Pharmaceuticals Major industry is somewhat better than the same rating for VKTX (91) in the Biotechnology industry. This means that KRYS’s stock grew somewhat faster than VKTX’s over the last 12 months.

VKTX's Price Growth Rating (48) in the Biotechnology industry is in the same range as KRYS (58) in the Pharmaceuticals Major industry. This means that VKTX’s stock grew similarly to KRYS’s over the last 12 months.

KRYS's P/E Growth Rating (97) in the Pharmaceuticals Major industry is in the same range as VKTX (100) in the Biotechnology industry. This means that KRYS’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KRYSVKTX
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
78%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
81%
Declines
ODDS (%)
Bearish Trend 25 days ago
75%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USPVX32.360.36
+1.13%
Union Street Partners Value A
CVTRX52.920.41
+0.78%
Calamos Growth & Income A
GSXIX42.390.28
+0.66%
abrdn US Small Cap Equity Inst Svc
VITPX105.34N/A
N/A
Vanguard Instl Ttl Stk Mkt Idx InstlPls
QRSIX42.81N/A
N/A
FPA Queens Road Small Cap Value Instl

KRYS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KRYS has been loosely correlated with XNCR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if KRYS jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KRYS
1D Price
Change %
KRYS100%
+0.89%
XNCR - KRYS
56%
Loosely correlated
+4.02%
CRNX - KRYS
56%
Loosely correlated
+1.67%
IDYA - KRYS
56%
Loosely correlated
+7.31%
ACLX - KRYS
55%
Loosely correlated
+2.52%
SYRE - KRYS
54%
Loosely correlated
+8.00%
More